Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition
Alessandro Papa, Silvia Pasquini, Chiara Contri, et al.
Cells (2022) Vol. 11, Iss. 3, pp. 471-471
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

“Magic Chloro”: Profound Effects of the Chlorine Atom in Drug Discovery
Debora Chiodi, Yoshihiro Ishihara
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 8, pp. 5305-5331
Open Access | Times Cited: 110
Polypharmacology: promises and new drugs in 2022
Piotr Ryszkiewicz, Barbara Malinowska, Eberhard Schlicker
Pharmacological Reports (2023) Vol. 75, Iss. 4, pp. 755-770
Open Access | Times Cited: 27
MAGL protects against renal fibrosis through inhibiting tubular cell lipotoxicity
Shan Zhou, Xian Ling, Jielin Zhu, et al.
Theranostics (2024) Vol. 14, Iss. 4, pp. 1583-1601
Open Access | Times Cited: 8
A Therapeutic Perspective of HDAC8 in Different Diseases: An Overview of Selective Inhibitors
Anna Fontana, Ilaria Cursaro, Gabriele Carullo, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 10014-10014
Open Access | Times Cited: 29
Potential Therapeutic Targets to Modulate the Endocannabinoid System in Alzheimer’s Disease
Hina Kanwal, Moris Sangineto, Martina Ciarnelli, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 4050-4050
Open Access | Times Cited: 7
Sleep, Glial Function, and the Endocannabinoid System: Implications for Neuroinflammation and Sleep Disorders
Josué Camberos-Barraza, Alejandro Camacho-Zamora, José Candelario Bátiz-Beltrán, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3160-3160
Open Access | Times Cited: 6
Development of Potent and Selective Monoacylglycerol Lipase Inhibitors. SARs, Structural Analysis, and Biological Characterization
Stefania Butini, Uwe Grether, Kwang‐Mook Jung, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 3, pp. 1758-1782
Open Access | Times Cited: 4
Xixin Decoction’s novel mechanism for alleviating Alzheimer’s disease cognitive dysfunction by modulating amyloid-β transport across the blood–brain barrier to reduce neuroinflammation
Chuanbin Yang, En-Long Zhao, Hu Zhang, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
Effect of “magic chlorine” in drug discovery: an in silico approach
Sravani Joshi, Ruby Srivastava
RSC Advances (2023) Vol. 13, Iss. 49, pp. 34922-34934
Open Access | Times Cited: 9
Endocannabinoids at the synapse and beyond: implications for neuropsychiatric disease pathophysiology and treatment
Andrew F. Scheyer, Farhana Yasmin, Saptarnab Naskar, et al.
Neuropsychopharmacology (2022) Vol. 48, Iss. 1, pp. 37-53
Closed Access | Times Cited: 15
Potent dual MAGL/FAAH inhibitor AKU-005 engages endocannabinoids to diminish meningeal nociception implicated in migraine pain
Adriana Della Pietra, Georgii Krivoshein, Konstantin Ivanov, et al.
The Journal of Headache and Pain (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 9
Pioneering first‐in‐class FAAH‐HDAC inhibitors as potential multitarget neuroprotective agents
Alessandro Papa, Ilaria Cursaro, Luca Pozzetti, et al.
Archiv der Pharmazie (2023) Vol. 356, Iss. 12
Open Access | Times Cited: 7
Inhibiting Endocannabinoid Hydrolysis as Emerging Analgesic Strategy Targeting a Spectrum of Ion Channels Implicated in Migraine Pain
Adriana Della Pietra, Juha R. Savinainen, Rashid Giniatullin
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4407-4407
Open Access | Times Cited: 12
Development of potent and selective FAAH inhibitors with improved drug-like properties as potential tools to treat neuroinflammatory conditions
Alessandro Papa, Silvia Pasquini, Francesca Galvani, et al.
European Journal of Medicinal Chemistry (2022) Vol. 246, pp. 114952-114952
Closed Access | Times Cited: 11
Enzymatic Metabolic Switches of Astrocyte Response to Lipotoxicity as Potential Therapeutic Targets for Nervous System Diseases
Andrea Angarita-Rodríguez, J. Manuel Matiz‐González, Andrés Pinzón, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 648-648
Open Access | Times Cited: 2
The polypharmacology of natural products in drug discovery and development
Malcolm Z. Y. Choo, Christina L. L. Chai
Annual reports in medicinal chemistry (2023), pp. 55-100
Closed Access | Times Cited: 5
Comparing therapeutic modulators of the SOD1 G93A Amyotrophic Lateral Sclerosis mouse pathophysiology
Albert J. B. Lee, Tyler E. Kittel, Renaid B. Kim, et al.
Frontiers in Neuroscience (2023) Vol. 16
Open Access | Times Cited: 4
Interplay between the Glymphatic System and the Endocannabinoid System: Implications for Brain Health and Disease
Juan Fidel Osuna‐Ramos, Josué Camberos-Barraza, Laura E. Torres-Mondragón, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17458-17458
Open Access | Times Cited: 4
Endocannabinoid-mediated rescue of somatosensory cortex activity, plasticity and related behaviors following an early in life concussion
Jérôme Badaut, Lea Hippauf, M. Malinconi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Neuropharmacological computational analysis of longitudinal electroencephalograms in clozapine-treated patients with schizophrenia using hierarchical dynamic causal modeling
Jinseok Eo, Jiyoung Kang, Tak Youn, et al.
NeuroImage (2023) Vol. 275, pp. 120161-120161
Open Access | Times Cited: 3
Weak Hypotensive Effect of Chronic Administration of the Dual FAAH/MAGL Inhibitor JZL195 in Spontaneously Hypertensive Rats as Revealed by Area under the Curve Analysis
Marek Toczek, Piotr Ryszkiewicz, Patryk Remiszewski, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10942-10942
Open Access | Times Cited: 3
“Magic Chloro”: Profound Effects of the Chlorine Atom in Drug Discovery
Debora Chiodi, Yoshihiro Ishihara
(2022)
Open Access | Times Cited: 5
Anandamide reduces the migration of lymphocytes to the intestine by CB2 activation and reduces TNF-α in the target organs, protecting mice from graft-versus-host disease
Bárbara Betônico Berg, Ana Flávia Santos Linhares, Daniel Messias Martins, et al.
European Journal of Pharmacology (2023) Vol. 956, pp. 175932-175932
Closed Access | Times Cited: 2
Molecular Basis for Non-Covalent, Non-Competitive FAAH Inhibition
Carmine Marco Morgillo, Antonio Lupia, Alessandro Deplano, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 15502-15502
Open Access | Times Cited: 4
The State of Synthetic Cannabinoid Medications for the Treatment of Pain
Anca Maglaviceanu, Miki Peer, Jason S. Rockel, et al.
CNS Drugs (2024) Vol. 38, Iss. 8, pp. 597-612
Closed Access
Page 1 - Next Page

Scroll to top